Deep, focused upcoming-technology sequencing has exposed that subclonal mutations (i.e., Those people current in only a portion of tumor cells) is often detected for all driver genes and therefore are associated with swift condition progression and bad end result.11–13 This is especially appropriate for TP53 mutations specified the fact that, as